Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Mini-Review Article

Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives

Author(s): Rasha Irshad, Sazi Tabassum and Mohammad Husain*

Volume 23, Issue 12, 2023

Published on: 29 May, 2023

Page: [1090 - 1103] Pages: 14

DOI: 10.2174/1568026623666230522103321

Price: $65

Abstract

It is now an undisputed fact that cancer cells undergo metabolic reprogramming to support their malignant phenotype, and it is one of the crucial hallmarks which enables cancer cells to facilitate their survival under variable conditions ranging from lack of nutrients to conditions, such as hypoxia. Recent developments in technologies, such as lipidomics and machine learning, have underlined the critical effects of altered lipid metabolism in tumorigenesis. The cancer cells show elevated de novo fatty acid synthesis, an increased capacity to scavenge lipids from their environment, and enhanced fatty acid oxidation to fulfill their need for uncontrolled cellular proliferation, immune evasion, tumor formation, angiogenesis, metastasis, and invasion. Besides, important genes/ proteins involved in lipid metabolism have been proposed as prognostic indicators in a variety of cancer types linked to tumor survival and/or recurrence. Consequently, several approaches are being explored to regulate this metabolic dysregulation to subvert its tumorigenic properties in different types of cancers. The present review details the significance of lipid metabolism in cancer progression, the critical enzymes involved therein, and their regulation.

Moreover, the current findings of the interplay between the oncogenic pathways and the lipid metabolic enzymes are elucidated briefly. The therapeutic implications of modulating these aberrations for the advancement of anti-cancer therapies are also discussed. Although the understanding of altered lipid metabolism in cancer initiation and progression is still in its infancy and somewhat obscure, its in-depth comprehension will open promising therapeutic opportunities for the development of novel and promising strategies for cancer treatment and management.

Graphical Abstract

[1]
Park, J.B.; Lee, C.S.; Jang, J.H.; Ghim, J.; Kim, Y.J.; You, S.; Hwang, D.; Suh, P.G.; Ryu, S.H. Phospholipase signalling networks in cancer. Nat. Rev. Cancer, 2012, 12(11), 782-792.
[http://dx.doi.org/10.1038/nrc3379] [PMID: 23076158]
[2]
Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell, 2011, 2011, 144.
[3]
Boroughs, L.K.; Deberardinis, R.J.; Cell, N.; Author, B. Metabolic pathways promoting cancer cell survival and growth HHS public access author manuscript. Nat. Cell Biol., 2015, 2015, 17.
[4]
Huang, J.; Li, L.; Lian, J.; Schauer, S.; Vesely, P.W.; Kratky, D.; Hoefler, G.; Lehner, R. Tumor-induced hyperlipidemia contributes to tumor growth. Cell Rep., 2016, 15(2), 336-348.
[http://dx.doi.org/10.1016/j.celrep.2016.03.020] [PMID: 27050512]
[5]
Menendez, J.A.; Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer, 2007, 7(10), 763-777.
[http://dx.doi.org/10.1038/nrc2222] [PMID: 17882277]
[6]
Zaidi, N.; Swinnen, J.V.; Smans, K. ATP-citrate lyase: A key player in cancer metabolism. Cancer Res., 2012, 72(15), 3709-3714.
[http://dx.doi.org/10.1158/0008-5472.CAN-11-4112] [PMID: 22787121]
[7]
Liu, Q.; Luo, Q.; Halim, A.; Song, G. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer. Cancer Lett., 2017, 401, 39-45.
[http://dx.doi.org/10.1016/j.canlet.2017.05.002] [PMID: 28527945]
[8]
Mashima, T.; Seimiya, H.; Tsuruo, T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer, 2009, 100(9), 1369-1372.
[http://dx.doi.org/10.1038/sj.bjc.6605007] [PMID: 19352381]
[9]
Rysman, E.; Brusselmans, K.; Scheys, K.; Timmermans, L.; Derua, R.; Munck, S.; Van Veldhoven, P.P.; Waltregny, D.; Daniëls, V.W.; Machiels, J.; Vanderhoydonc, F.; Smans, K.; Waelkens, E.; Verhoeven, G.; Swinnen, J.V. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res., 2010, 70(20), 8117-8126.
[http://dx.doi.org/10.1158/0008-5472.CAN-09-3871] [PMID: 20876798]
[10]
Icard, P.; Wu, Z.; Fournel, L.; Coquerel, A.; Lincet, H.; Alifano, M. ATP citrate lyase: A central metabolic enzyme in cancer. Cancer Lett., 2020, 471, 125-134.
[http://dx.doi.org/10.1016/j.canlet.2019.12.010] [PMID: 31830561]
[11]
Granchi, C. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism. Eur. J. Med. Chem., 2018, 157, 1276-1291.
[http://dx.doi.org/10.1016/j.ejmech.2018.09.001] [PMID: 30195238]
[12]
Hatzivassiliou, G.; Zhao, F.; Bauer, D.E.; Andreadis, C.; Shaw, A.N.; Dhanak, D.; Hingorani, S.R.; Tuveson, D.A.; Thompson, C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell, 2005, 8(4), 311-321.
[http://dx.doi.org/10.1016/j.ccr.2005.09.008] [PMID: 16226706]
[13]
Qian, X.; Hu, J.; Zhao, J.; Chen, H. ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma. Int. J. Clin. Exp. Med., 2015, 8(5), 7855-7860.
[PMID: 26221340]
[14]
Hanai, J.; Doro, N.; Sasaki, A.T.; Kobayashi, S.; Cantley, L.C.; Seth, P.; Sukhatme, V.P. Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways. J. Cell. Physiol., 2012, 227(4), 1709-1720.
[http://dx.doi.org/10.1002/jcp.22895] [PMID: 21688263]
[15]
Sun, H.; Wang, F.; Huang, Y.; Wang, J.; Zhang, L.; Shen, Y.; Lin, C.; Guo, P. Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma. J. Cancer, 2022, 13(3), 951-964.
[http://dx.doi.org/10.7150/jca.52778] [PMID: 35154461]
[16]
Hunkeler, M.; Hagmann, A.; Stuttfeld, E.; Chami, M.; Guri, Y.; Stahlberg, H.; Maier, T. Structural basis for regulation of human acetyl-CoA carboxylase. Nature, 2018, 558(7710), 470-474.
[http://dx.doi.org/10.1038/s41586-018-0201-4] [PMID: 29899443]
[17]
Svensson, R.U.; Parker, S.J.; Eichner, L.J.; Kolar, M.J.; Wallace, M.; Brun, S.N.; Lombardo, P.S.; Van Nostrand, J.L.; Hutchins, A.; Vera, L.; Gerken, L.; Greenwood, J.; Bhat, S.; Harriman, G.; Westlin, W.F.; Harwood, H.J., Jr; Saghatelian, A.; Kapeller, R.; Metallo, C.M.; Shaw, R.J. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Nat. Med., 2016, 22(10), 1108-1119.
[http://dx.doi.org/10.1038/nm.4181] [PMID: 27643638]
[18]
Lally, J.S.V.; Ghoshal, S.; DePeralta, D.K.; Moaven, O.; Wei, L.; Masia, R.; Erstad, D.J.; Fujiwara, N.; Leong, V.; Houde, V.P.; Anagnostopoulos, A.E.; Wang, A.; Broadfield, L.A.; Ford, R.J.; Foster, R.A.; Bates, J.; Sun, H.; Wang, T.; Liu, H.; Ray, A.S.; Saha, A.K.; Greenwood, J.; Bhat, S.; Harriman, G.; Miao, W.; Rocnik, J.L.; Westlin, W.F.; Muti, P.; Tsakiridis, T.; Harwood, H.J., Jr; Kapeller, R.; Hoshida, Y.; Tanabe, K.K.; Steinberg, G.R.; Fuchs, B.C. Inhibition of acetyl-coa carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma. Cell Metab., 2019, 29(1), 174-182.e5.
[http://dx.doi.org/10.1016/j.cmet.2018.08.020] [PMID: 30244972]
[19]
Butler, L.M.; Mah, C.Y.; Machiels, J.; Vincent, A.D.; Irani, S.; Mutuku, S.M.; Spotbeen, X.; Bagadi, M.; Waltregny, D.; Moldovan, M.; Dehairs, J.; Vanderhoydonc, F.; Bloch, K.; Das, R.; Stahl, J.; Kench, J.G.; Gevaert, T.; Derua, R.; Waelkens, E.; Nassar, Z.D.; Selth, L.A.; Trim, P.J.; Snel, M.F.; Lynn, D.J.; Tilley, W.D.; Horvath, L.G.; Centenera, M.M.; Swinnen, J.V. Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition. Cancer Res., 2021, 81(19), 4981-4993.
[http://dx.doi.org/10.1158/0008-5472.CAN-20-3863] [PMID: 34362796]
[20]
Chirala, S.S.; Wakil, S.J. Structure and Function of Animal Fatty Acid Synthase Lipids, 2004, 39(11), 1045-53.
[http://dx.doi.org/10.1007/s11745-004-1329-9]
[21]
Flavin, R.; Peluso, S.; Nguyen, P.L.; Loda, M. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol., 2010, 6(4), 551-562.
[http://dx.doi.org/10.2217/fon.10.11] [PMID: 20373869]
[22]
Bauerschlag, D.O.; Maass, N.; Leonhardt, P.; Verburg, F.A.; Pecks, U.; Zeppernick, F.; Morgenroth, A.; Mottaghy, F.M.; Tolba, R.; Meinhold-Heerlein, I.; Bräutigam, K. Fatty acid synthase overexpression: Target for therapy and reversal of chemoresistance in ovarian cancer. J. Transl. Med., 2015, 13(1), 146.
[http://dx.doi.org/10.1186/s12967-015-0511-3] [PMID: 25947066]
[23]
Oh, J.E.; Jung, B.H.; Park, J.; Kang, S.; Lee, H. Deciphering fatty acid synthase inhibition-triggered metabolic flexibility in prostate cancer cells through untargeted metabolomics. Cells, 2020, 9(11), 2447.
[http://dx.doi.org/10.3390/cells9112447] [PMID: 33182594]
[24]
Fhu, C.W.; Ali, A. Fatty acid synthase: An emerging target in cancer. Molecules, 2020, 25(17), 3935.
[http://dx.doi.org/10.3390/molecules25173935] [PMID: 32872164]
[25]
Yu, Y.; Kim, H.; Choi, S.; Yu, J.; Lee, J.Y.; Lee, H.; Yoon, S.; Kim, W.Y. Targeting a lipid desaturation enzyme, SCD1, selectively eliminates colon cancer stem cells through the suppression of Wnt and NOTCH signaling. Cells, 2021, 10(1), 106.
[http://dx.doi.org/10.3390/cells10010106] [PMID: 33430034]
[26]
Liu, Y.; Liu, X.; Wang, H.; Ding, P.; Wang, C. Agrimonolide inhibits cancer progression and induces ferroptosis and apoptosis by targeting SCD1 in ovarian cancer cells. Phytomedicine, 2022, 101, 154102.
[http://dx.doi.org/10.1016/j.phymed.2022.154102] [PMID: 35526323]
[27]
Noto, A.; Raffa, S.; De Vitis, C.; Roscilli, G.; Malpicci, D.; Coluccia, P.; Di Napoli, A.; Ricci, A.; Giovagnoli, M.R.; Aurisicchio, L.; Torrisi, M.R.; Ciliberto, G.; Mancini, R. Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells. Cell Death Dis., 2013, 4(12), e947.
[http://dx.doi.org/10.1038/cddis.2013.444] [PMID: 24309934]
[28]
Guo, W.; Tan, H.Y.; Chen, F.; Wang, N.; Feng, Y. Targeting cancer metabolism to resensitize chemotherapy: Potential development of cancer chemosensitizers from traditional chinese medicines. Cancers , 2020, 12(2), 404.
[http://dx.doi.org/10.3390/cancers12020404] [PMID: 32050640]
[29]
Padanad, M.S.; Konstantinidou, G.; Venkateswaran, N.; Melegari, M.; Rindhe, S.; Mitsche, M.; Yang, C.; Batten, K.; Huffman, K.E.; Liu, J.; Tang, X.; Rodriguez-Canales, J.; Kalhor, N.; Shay, J.W.; Minna, J.D.; McDonald, J.; Wistuba, I.I.; DeBerardinis, R.J.; Scaglioni, P.P. Fatty acid oxidation mediated by Acyl-CoA synthetase long chain 3 is required for mutant KRAS lung tumorigenesis. Cell Rep., 2016, 16(6), 1614-1628.
[http://dx.doi.org/10.1016/j.celrep.2016.07.009] [PMID: 27477280]
[30]
Nomura, D.K.; Long, J.Z.; Niessen, S.; Hoover, H.S.; Ng, S.W.; Cravatt, B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell, 2010, 140(1), 49-61.
[http://dx.doi.org/10.1016/j.cell.2009.11.027] [PMID: 20079333]
[31]
Nomura, D.K.; Lombardi, D.P.; Chang, J.W.; Niessen, S.; Ward, A.M.; Long, J.Z.; Hoover, H.H.; Cravatt, B.F. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem. Biol., 2011, 18(7), 846-856.
[http://dx.doi.org/10.1016/j.chembiol.2011.05.009] [PMID: 21802006]
[32]
Zhang, J.; Liu, Z.; Lian, Z.; Liao, R.; Chen, Y.; Qin, Y.; Wang, J.; Jiang, Q.; Wang, X.; Gong, J. Monoacylglycerol lipase: A novel potential therapeutic target and prognostic indicator for hepatocellular carcinoma. Sci. Rep., 2016, 6(1), 35784.
[http://dx.doi.org/10.1038/srep35784] [PMID: 27767105]
[33]
Gil-Ordóñez, A.; Martín-Fontecha, M.; Ortega-Gutiérrez, S.; López-Rodríguez, M.L. Monoacylglycerol lipase (MAGL) as a promising therapeutic target. Biochem. Pharmacol., 2018, 157, 18-32.
[http://dx.doi.org/10.1016/j.bcp.2018.07.036] [PMID: 30059673]
[34]
Jha, V.; Biagi, M.; Spinelli, V.; Di Stefano, M.; Macchia, M.; Minutolo, F.; Granchi, C.; Poli, G.; Tuccinardi, T. Discovery of Monoacylglycerol Lipase (MAGL) inhibitors based on a pharmacophore-guided virtual screening study. Molecules, 2020, 26(1), 78.
[http://dx.doi.org/10.3390/molecules26010078] [PMID: 33375358]
[35]
Poli, G.; Lapillo, M.; Jha, V.; Mouawad, N.; Caligiuri, I.; Macchia, M.; Minutolo, F.; Rizzolio, F.; Tuccinardi, T.; Granchi, C. Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. J. Enzyme Inhib. Med. Chem., 2019, 34(1), 589-596.
[http://dx.doi.org/10.1080/14756366.2019.1571271] [PMID: 30696302]
[36]
Wang, B.; Tontonoz, P. Phospholipid remodeling in physiology and disease. Annu. Rev. Physiol., 2019, 81(1), 165-188.
[http://dx.doi.org/10.1146/annurev-physiol-020518-114444] [PMID: 30379616]
[37]
Cummings, B.S. Phospholipase A2 as targets for anti-cancer drugs. Biochem. Pharmacol., 2007, 74(7), 949-959.
[http://dx.doi.org/10.1016/j.bcp.2007.04.021] [PMID: 17531957]
[38]
Vecchi, L.; Araújo, T.G.; Azevedo, F.V.P.V.; Mota, S.T.S.; Ávila, V.M.R.; Ribeiro, M.A.; Goulart, L.R. Phospholipase A2 drives tumorigenesis and cancer aggressiveness through its interaction with Annexin A1. Cells, 2021, 10(6), 1472.
[http://dx.doi.org/10.3390/cells10061472] [PMID: 34208346]
[39]
Yamashita, S.I.; Yamashita, J.I.; Sakamoto, K.; Inada, K.; Nakashima, Y.; Murata, K.; Saishoji, T.; Nomura, K.; Ogawa, M. Increased expression of membrane-associated phospholipase A2 shows malignant potential of human breast cancer cells. Cancer, 1993, 71(10), 3058-3064.
[http://dx.doi.org/10.1002/1097-0142(19930515)71:10<3058:AID-CNCR2820711028>3.0.CO;2-8] [PMID: 8490834]
[40]
Perestrelo, R.; Petkovic, M.; Silva, C.L. Analytical platforms for the determination of phospholipid turnover in breast cancer tissue: Role of phospholipase activity in breast cancer development. Metabolites, 2021, 11(1), 32.
[http://dx.doi.org/10.3390/metabo11010032] [PMID: 33406793]
[41]
Huang, C.; Freter, C. Lipid metabolism, apoptosis and cancer therapy. Int. J. Mol. Sci., 2015, 16(1), 924-949.
[http://dx.doi.org/10.3390/ijms16010924] [PMID: 25561239]
[42]
Liscovitch, M.; Czarny, M.; Fiucci, G.; Lavie, Y.; Tang, X. Localization and possible functions of phospholipase D isozymes. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1999, 1439(2), 245-263.
[http://dx.doi.org/10.1016/S1388-1981(99)00098-0] [PMID: 10425399]
[43]
Xu, L.; Shen, Y.; Joseph, T.; Bryant, A.; Luo, J.Q.; Frankel, P.; Rotunda, T.; Foster, D.A. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains. Biochem. Biophys. Res. Commun., 2000, 273(1), 77-83.
[http://dx.doi.org/10.1006/bbrc.2000.2907] [PMID: 10873567]
[44]
Xu, L.; Frankel, P.; Jackson, D.; Rotunda, T.; Boshans, R.L.; D’Souza-Schorey, C.; Foster, D.A. Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6. Mol. Cell. Biol., 2003, 23(2), 645-654.
[http://dx.doi.org/10.1128/MCB.23.2.645-654.2003] [PMID: 12509462]
[45]
Yao, Y.; Wang, X.; Li, H.; Fan, J.; Qian, X.; Li, H.; Xu, Y. Phospholipase D as a key modulator of cancer progression. Biol. Rev. Camb. Philos. Soc., 2020, 95(4), 911-935.
[http://dx.doi.org/10.1111/brv.12592] [PMID: 32073216]
[46]
Cho, J.H.; Han, J.S. Phospholipase D and its essential role in cancer. Mol. Cells, 2017, 40(11), 805-813.
[PMID: 29145720]
[47]
Eder, A.M.; Sasagawa, T.; Mao, M.; Aoki, J.; Mills, G.B. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2. Clin. Cancer Res., 2000, 6(6), 2482-2491.
[PMID: 10873103]
[48]
Hsu, Y.L.; Hung, J.Y.; Ko, Y.C.; Hung, C.H.; Huang, M.S.; Kuo, P.L.; Phospholipase, D. Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis. Carcinogenesis, 2010, 31(4), 587-596.
[http://dx.doi.org/10.1093/carcin/bgq030] [PMID: 20106902]
[49]
Qi, C.; Park, J.H.; Gibbs, T.C.; Shirley, D.W.; Bradshaw, C.D.; Ella, K.M.; Meier, K.E. Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells. J. Cell. Physiol., 1998, 174(2), 261-272.
[http://dx.doi.org/10.1002/(SICI)1097-4652(199802)174:2<261:AID-JCP13>3.0.CO;2-F] [PMID: 9428812]
[50]
Bruntz, R.C.; Lindsley, C.W.; Brown, H.A.; Phospholipase, D. Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer. Pharmacol. Rev., 2014, 66(4), 1033-1079.
[http://dx.doi.org/10.1124/pr.114.009217] [PMID: 25244928]
[51]
Kang, D.W.; Lee, S.W.; Hwang, W.C.; Lee, B.H.; Choi, Y.S.; Suh, Y.A.; Choi, K.Y.; Min, D.S. Phospholipase D1 acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent apoptotic program in cancer cells. Cancer Res., 2017, 77(1), 142-152.
[http://dx.doi.org/10.1158/0008-5472.CAN-15-3032] [PMID: 27793841]
[52]
Kang, D.W.; Lee, B.H.; Suh, Y.A.; Choi, Y.S.; Jang, S.J.; Kim, Y.M.; Choi, K.Y.; Min, D.S. Phospholipase D1 Inhibition linked to upregulation of ICAT blocks colorectal cancer growth hyperactivated by Wnt/β/β-Catenin and PI3K/Akt signaling. Clin. Cancer Res., 2017, 23(23), 7340-7350.
[http://dx.doi.org/10.1158/1078-0432.CCR-17-0749] [PMID: 28939743]
[53]
Qu, Q.; Zeng, F.; Liu, X.; Wang, Q.J.; Deng, F. Fatty acid oxidation and carnitine palmitoyltransferase I: Emerging therapeutic targets in cancer. Cell Death Dis., 2016, 7(5), e2226.
[http://dx.doi.org/10.1038/cddis.2016.132] [PMID: 27195673]
[54]
Bian, X.; Liu, R.; Meng, Y.; Xing, D.; Xu, D.; Lu, Z. Lipid metabolism and cancer. J. Exp. Med., 2021, 218(1), e20201606.
[http://dx.doi.org/10.1084/jem.20201606] [PMID: 33601415]
[55]
Gatza, M.L.; Silva, G.O.; Parker, J.S.; Fan, C.; Perou, C.M. An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer. Nat. Genet., 2014, 46(10), 1051-1059.
[http://dx.doi.org/10.1038/ng.3073] [PMID: 25151356]
[56]
Yeh, C.S.; Wang, J.Y.; Cheng, T.L.; Juan, C.H.; Wu, C.H.; Lin, S.R. Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. Cancer Lett., 2006, 233(2), 297-308.
[http://dx.doi.org/10.1016/j.canlet.2005.03.050] [PMID: 15885896]
[57]
Wang, R.; Cheng, Y.; Su, D.; Gong, B.; He, X.; Zhou, X.; Pang, Z.; Cheng, L.; Chen, Y.; Yao, Z. Cpt1c regulated by AMPK promotes papillary thyroid carcinomas cells survival under metabolic stress conditions. J. Cancer, 2017, 8(18), 3675-3681.
[http://dx.doi.org/10.7150/jca.21148] [PMID: 29151954]
[58]
Cha, Y.; Kim, H.; Koo, J. Expression of lipid metabolism-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. Int. J. Mol. Sci., 2017, 18(1), 232.
[http://dx.doi.org/10.3390/ijms18010232] [PMID: 28124996]
[59]
Jeon, T.I.; Osborne, T.F. SREBPs: Metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab., 2012, 23(2), 65-72.
[http://dx.doi.org/10.1016/j.tem.2011.10.004] [PMID: 22154484]
[60]
Santos, C.R.; Schulze, A. Lipid metabolism in cancer. FEBS J., 2012, 279(15), 2610-2623.
[http://dx.doi.org/10.1111/j.1742-4658.2012.08644.x] [PMID: 22621751]
[61]
Cheng, C.; Geng, F.; Cheng, X.; Guo, D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun., 2018, 38(1), 27.
[http://dx.doi.org/10.1186/s40880-018-0301-4] [PMID: 29784041]
[62]
Espenshade, P.J.; Li, W.P.; Yabe, D. Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER. Proc. Natl. Acad. Sci. USA, 2002, 99(18), 11694-11699.
[http://dx.doi.org/10.1073/pnas.182412799] [PMID: 12193656]
[63]
Huang, W.C.; Li, X.; Liu, J.; Lin, J.; Chung, L.W.K. Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol. Cancer Res., 2012, 10(1), 133-142.
[http://dx.doi.org/10.1158/1541-7786.MCR-11-0206] [PMID: 22064655]
[64]
Bao, J.; Zhu, L.; Zhu, Q.; Su, J.; Liu, M.; Huang, W. SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer. Oncol. Lett., 2016, 12(4), 2409-2416.
[http://dx.doi.org/10.3892/ol.2016.4988] [PMID: 27703522]
[65]
Li, C.; Yang, W.; Zhang, J.; Zheng, X.; Yao, Y.; Tu, K.; Liu, Q. SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int. J. Mol. Sci., 2014, 15(5), 7124-7138.
[http://dx.doi.org/10.3390/ijms15057124] [PMID: 24776759]
[66]
Wang, Y.; Wang, H.; Zhao, Q.; Xia, Y.; Hu, X.; Guo, J. PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma. Med. Oncol., 2015, 32(8), 212.
[http://dx.doi.org/10.1007/s12032-015-0655-2] [PMID: 26141060]
[67]
Li, X.; Wu, J.B.; Li, Q.; Shigemura, K.; Chung, L.W.K.; Huang, W.C. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget, 2016, 7(11), 12869-12884.
[http://dx.doi.org/10.18632/oncotarget.7331] [PMID: 26883200]
[68]
Zhang, B.; Wu, J.; Guo, P.; Wang, Y.; Fang, Z.; Tian, J.; Yu, Y.; Teng, W.; Yingbin, L.; Li, Y. Down-regulation of SREBP via PI3K/AKT/mTOR pathway inhibits the proliferation and invasion of non-small-cell lung cancer cells. OncoTargets Ther., 2020, 13, 8951-8961.
[http://dx.doi.org/10.2147/OTT.S266073] [PMID: 32982287]
[69]
Luo, X.; Zhao, X.; Cheng, C.; Li, N.; Liu, Y.; Cao, Y. The implications of signaling lipids in cancer metastasis. Exp. Mol. Med., 2018, 50(9), 1-10.
[http://dx.doi.org/10.1038/s12276-018-0150-x] [PMID: 30242145]
[70]
Ricoult, S.J.H.; Yecies, J.L.; Ben-Sahra, I.; Manning, B.D. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP. Oncogene, 2016, 35(10), 1250-1260.
[http://dx.doi.org/10.1038/onc.2015.179] [PMID: 26028026]
[71]
Li, Y.; Wu, S.; Zhao, X.; Hao, S.; Li, F.; Wang, Y.; Liu, B.; Zhang, D.; Wang, Y.; Zhou, H. Key events in cancer: Dysregulation of SREBPs. Front. Pharmacol., 2023, 14, 1130747.
[http://dx.doi.org/10.3389/fphar.2023.1130747] [PMID: 36969840]
[72]
Porstmann, T.; Santos, C.R.; Griffiths, B.; Cully, M.; Wu, M.; Leevers, S.; Griffiths, J.R.; Chung, Y.L.; Schulze, A. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab., 2008, 8(3), 224-236.
[http://dx.doi.org/10.1016/j.cmet.2008.07.007] [PMID: 18762023]
[73]
Grunt, T.W. Interacting cancer machineries: Cell signaling, lipid metabolism, and epigenetics. Trends Endocrinol. Metab., 2018, 29(2), 86-98.
[http://dx.doi.org/10.1016/j.tem.2017.11.003] [PMID: 29203141]
[74]
Freed-Pastor, W.A.; Mizuno, H.; Zhao, X.; Langerød, A.; Moon, S.H.; Rodriguez-Barrueco, R.; Barsotti, A.; Chicas, A.; Li, W.; Polotskaia, A.; Bissell, M.J.; Osborne, T.F.; Tian, B.; Lowe, S.W.; Silva, J.M.; Børresen-Dale, A.L.; Levine, A.J.; Bargonetti, J.; Prives, C. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell, 2012, 148(1-2), 244-258.
[http://dx.doi.org/10.1016/j.cell.2011.12.017] [PMID: 22265415]
[75]
Auciello, F.R.; Bulusu, V.; Oon, C.; Tait-Mulder, J.; Berry, M.; Bhattacharyya, S.; Tumanov, S.; Allen-Petersen, B.L.; Link, J.; Kendsersky, N.D.; Vringer, E.; Schug, M.; Novo, D.; Hwang, R.F.; Evans, R.M.; Nixon, C.; Dorrell, C.; Morton, J.P.; Norman, J.C.; Sears, R.C.; Kamphorst, J.J.; Sherman, M.H. A stromal lysolipid–autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discov., 2019, 9(5), 617-627.
[http://dx.doi.org/10.1158/2159-8290.CD-18-1212] [PMID: 30837243]
[76]
Schulze, A.; Harris, A.L. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature, 2012, 491(7424), 364-373.
[http://dx.doi.org/10.1038/nature11706] [PMID: 23151579]
[77]
Baenke, F.; Peck, B.; Miess, H.; Schulze, A. Hooked on fat: The role of lipid synthesis in cancer metabolism and tumour development. Dis. Model. Mech., 2013, 6(6), 1353-1363.
[http://dx.doi.org/10.1242/dmm.011338] [PMID: 24203995]
[78]
Gansler, T.S.; Hardman, W., III; Hunt, D.A.; Schaffel, S.; Hennigar, R.A. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum. Pathol., 1997, 28(6), 686-692.
[http://dx.doi.org/10.1016/S0046-8177(97)90177-5] [PMID: 9191002]
[79]
Migita, T.; Ruiz, S.; Fornari, A.; Fiorentino, M.; Priolo, C.; Zadra, G.; Inazuka, F.; Grisanzio, C.; Palescandolo, E.; Shin, E.; Fiore, C.; Xie, W.; Kung, A.L.; Febbo, P.G.; Subramanian, A.; Mucci, L.; Ma, J.; Signoretti, S.; Stampfer, M.; Hahn, W.C.; Finn, S.; Loda, M. Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer. J. Natl. Cancer Inst., 2009, 101(7), 519-532.
[http://dx.doi.org/10.1093/jnci/djp030] [PMID: 19318631]
[80]
Broadfield, L.A.; Pane, A.A.; Talebi, A.; Swinnen, J.V.; Fendt, S.M. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev. Cell, 2021, 56(10), 1363-1393.
[http://dx.doi.org/10.1016/j.devcel.2021.04.013] [PMID: 33945792]
[81]
Diao, X.Y.; Lin, T. Progress in therapeutic strategies based on cancer lipid metabolism. Thorac. Cancer, 2019, 10(9), 1741-1743.
[http://dx.doi.org/10.1111/1759-7714.13146] [PMID: 31328418]
[82]
Pascual, G.; Avgustinova, A.; Mejetta, S.; Martín, M.; Castellanos, A.; Attolini, C.S.O.; Berenguer, A.; Prats, N.; Toll, A.; Hueto, J.A.; Bescós, C.; Di Croce, L.; Benitah, S.A. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature, 2017, 541(7635), 41-45.
[http://dx.doi.org/10.1038/nature20791] [PMID: 27974793]
[83]
Li, Z.; Kang, Y. Lipid metabolism fuels cancer’s spread. Cell Metab., 2017, 25(2), 228-230.
[http://dx.doi.org/10.1016/j.cmet.2017.01.016] [PMID: 28178563]
[84]
Pan, J.; Fan, Z.; Wang, Z.; Dai, Q.; Xiang, Z.; Yuan, F.; Yan, M.; Zhu, Z.; Liu, B.; Li, C. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β/-catenin pathway. J. Exp. Clin. Cancer Res., 2019, 38(1), 52.
[http://dx.doi.org/10.1186/s13046-019-1049-7] [PMID: 30717785]
[85]
Ladanyi, A.; Mukherjee, A.; Kenny, H.A.; Johnson, A.; Mitra, A.K.; Sundaresan, S.; Nieman, K.M.; Pascual, G.; Benitah, S.A.; Montag, A.; Yamada, S.D.; Abumrad, N.A.; Lengyel, E. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene, 2018, 37(17), 2285-2301.
[http://dx.doi.org/10.1038/s41388-017-0093-z] [PMID: 29398710]
[86]
Yoshida, T.; Yokobori, T.; Saito, H.; Kuriyama, K.; Kumakura, Y.; Honjo, H.; Hara, K.; Sakai, M.; Miyazaki, T.; Obinata, H.; Erkhem-Ochir, B.; Gombodorj, N.; Sohda, M.; Saeki, H.; Kuwano, H.; Shirabe, K. CD36 expression is associated with cancer aggressiveness and energy source in esophageal squamous cell carcinoma. Ann. Surg. Oncol., 2021, 28(2), 1217-1227.
[http://dx.doi.org/10.1245/s10434-020-08711-3] [PMID: 32529269]
[87]
Luo, X.; Zheng, E.; Wei, L.; Zeng, H.; Qin, H.; Zhang, X.; Liao, M.; Chen, L.; Zhao, L.; Ruan, X.Z.; Yang, P.; Chen, Y. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis. Cell Death Dis., 2021, 12(4), 328.
[http://dx.doi.org/10.1038/s41419-021-03596-w] [PMID: 33771982]
[88]
Ma, X.; Xiao, L.; Liu, L.; Ye, L.; Su, P.; Bi, E.; Wang, Q.; Yang, M.; Qian, J.; Yi, Q. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab., 2021, 33(5), 1001-1012.e5.
[http://dx.doi.org/10.1016/j.cmet.2021.02.015] [PMID: 33691090]
[89]
Kawaguchi, K.; Senga, S.; Kubota, C.; Kawamura, Y.; Ke, Y.; Fujii, H. High expression of Fatty AcidBinding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells. FEBS Open Bio, 2016, 6(3), 190-199.
[http://dx.doi.org/10.1002/2211-5463.12031] [PMID: 27047747]
[90]
Amiri, M.; Yousefnia, S.; Seyed Forootan, F.; Peymani, M.; Ghaedi, K.; Nasr Esfahani, M.H. Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers. Gene, 2018, 676, 171-183.
[http://dx.doi.org/10.1016/j.gene.2018.07.035] [PMID: 30021130]
[91]
Rao, E.; Singh, P.; Zhai, X.; Li, Y.; Zhu, G.; Zhang, Y.; Hao, J.; Chi, Y.I.; Brown, R.E.; Cleary, M.P.; Li, B. Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein. Oncotarget, 2015, 6(10), 7815-7827.
[http://dx.doi.org/10.18632/oncotarget.3485] [PMID: 25796556]
[92]
Wu, G.; Zhang, Z.; Tang, Q.; Liu, L.; Liu, W.; Li, Q.; Wang, Q. Study of FABP’s interactome and detecting new molecular targets in clear cell renal cell carcinoma. J. Cell. Physiol., 2020, 235(4), 3776-3789.
[http://dx.doi.org/10.1002/jcp.29272]
[93]
Li, X.; Chen, Y.T.; Hu, P.; Huang, W.C. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling. Mol. Cancer Ther., 2014, 13(4), 855-866.
[http://dx.doi.org/10.1158/1535-7163.MCT-13-0797] [PMID: 24493696]
[94]
Koundouros, N.; Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer, 2020, 122(1), 4-22.
[http://dx.doi.org/10.1038/s41416-019-0650-z] [PMID: 31819192]
[95]
Veigel, D.; Wagner, R.; Stübiger, G.; Wuczkowski, M.; Filipits, M.; Horvat, R.; Benhamú, B.; López-Rodríguez, M.L.; Leisser, A.; Valent, P.; Grusch, M.; Hegardt, F.G.; García, J.; Serra, D.; Auersperg, N.; Colomer, R.; Grunt, T.W. Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells. Int. J. Cancer, 2015, 136(9), 2078-2090.
[http://dx.doi.org/10.1002/ijc.29261] [PMID: 25302649]
[96]
Bauer, D.E.; Hatzivassiliou, G.; Zhao, F.; Andreadis, C.; Thompson, C.B. ATP citrate lyase is an important component of cell growth and transformation. Oncogene, 2005, 24(41), 6314-6322.
[http://dx.doi.org/10.1038/sj.onc.1208773] [PMID: 16007201]
[97]
Chajès, V.; Cambot, M.; Moreau, K.; Lenoir, G.M.; Joulin, V. Acetyl-CoA carboxylase α is essential to breast cancer cell survival. Cancer Res., 2006, 66(10), 5287-5294.
[http://dx.doi.org/10.1158/0008-5472.CAN-05-1489] [PMID: 16707454]
[98]
Knowles, L.M.; Axelrod, F.; Browne, C.D.; Smith, J.W. A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2. J. Biol. Chem., 2004, 279(29), 30540-30545.
[http://dx.doi.org/10.1074/jbc.M405061200] [PMID: 15138278]
[99]
Samudio, I.; Harmancey, R.; Fiegl, M.; Kantarjian, H.; Konopleva, M.; Korchin, B.; Kaluarachchi, K.; Bornmann, W.; Duvvuri, S.; Taegtmeyer, H.; Andreeff, M. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest., 2010, 120(1), 142-156.
[http://dx.doi.org/10.1172/JCI38942] [PMID: 20038799]
[100]
Vickers, A.E.M. Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors. Toxicol. Pathol., 2009, 37(1), 78-88.
[http://dx.doi.org/10.1177/0192623308329285] [PMID: 19234235]
[101]
Dobbins, R.L.; Szczepaniak, L.S.; Bentley, B.; Esser, V.; Myhill, J.; McGarry, J.D. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes, 2001, 50(1), 123-130.
[http://dx.doi.org/10.2337/diabetes.50.1.123] [PMID: 11147777]
[102]
Leamy, A.K.; Egnatchik, R.A.; Young, J.D. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog. Lipid Res., 2013, 52(1), 165-174.
[http://dx.doi.org/10.1016/j.plipres.2012.10.004] [PMID: 23178552]
[103]
Currie, E.; Schulze, A.; Zechner, R.; Walther, T.C.; Farese, R.V., Jr Cellular fatty acid metabolism and cancer. Cell Metab., 2013, 18(2), 153-161.
[http://dx.doi.org/10.1016/j.cmet.2013.05.017] [PMID: 23791484]
[104]
Schafer, Z.T.; Grassian, A.R.; Song, L.; Jiang, Z.; Gerhart-Hines, Z.; Irie, H.Y.; Gao, S.; Puigserver, P.; Brugge, J.S. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature, 2009, 461(7260), 109-113.
[http://dx.doi.org/10.1038/nature08268] [PMID: 19693011]
[105]
Carracedo, A.; Weiss, D.; Leliaert, A.K.; Bhasin, M.; de Boer, V.C.J.; Laurent, G.; Adams, A.C.; Sundvall, M.; Song, S.J.; Ito, K.; Finley, L.S.; Egia, A.; Libermann, T.; Gerhart-Hines, Z.; Puigserver, P.; Haigis, M.C.; Maratos-Flier, E.; Richardson, A.L.; Schafer, Z.T.; Pandolfi, P.P. A metabolic prosurvival role for PML in breast cancer. J. Clin. Invest., 2012, 122(9), 3088-3100.
[http://dx.doi.org/10.1172/JCI62129] [PMID: 22886304]
[106]
Schlaepfer, I.R.; Joshi, M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology, 2020, 161(2), bqz046.
[107]
Schlaepfer, I.R.; Rider, L.; Rodrigues, L.U.; Gijón, M.A.; Pac, C.T.; Romero, L.; Cimic, A.; Sirintrapun, S.J.; Glodé, L.M.; Eckel, R.H.; Cramer, S.D. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol. Cancer Ther., 2014, 13(10), 2361-2371.
[http://dx.doi.org/10.1158/1535-7163.MCT-14-0183] [PMID: 25122071]
[108]
Yang, H.; Deng, Q.; Ni, T. liu, Y.; Lu, L.; Dai, H.; Wang, H.; Yang, W. Targeted inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer. Int. J. Biol. Sci., 2021, 17(15), 4207-4222.
[http://dx.doi.org/10.7150/ijbs.64714] [PMID: 34803493]
[109]
Kim, W.T.; Yun, S.J.; Yan, C.; Jeong, P.; Kim, Y.H.; Lee, I.S.; Kang, H.W.; Park, S.; Moon, S.K.; Choi, Y.H.; Choi, Y.D.; Kim, I.Y.; Kim, J.; Kim, W.J. Metabolic pathway signatures associated with urinary metabolite biomarkers differentiate bladder cancer patients from healthy controls. Yonsei Med. J., 2016, 57(4), 865-871.
[http://dx.doi.org/10.3349/ymj.2016.57.4.865] [PMID: 27189278]
[110]
Lin, H.; Patel, S.; Affleck, V.S.; Wilson, I.; Turnbull, D.M.; Joshi, A.R.; Maxwell, R.; Stoll, E.A. Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells. Neuro-oncol., 2017, 19(1), 43-54.
[http://dx.doi.org/10.1093/neuonc/now128] [PMID: 27365097]
[111]
Ruidas, B.; Sur, T.K.; Das Mukhopadhyay, C.; Sinha, K.; Som Chaudhury, S.; Sharma, P.; Bhowmick, S.; Majumder, R.; Saha, A. Quercetin: A silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1. Breast Cancer, 2022, 29(4), 748-760.
[http://dx.doi.org/10.1007/s12282-022-01356-y]
[112]
Zaidi, N.; Lupien, L.; Kuemmerle, N.B.; Kinlaw, W.B.; Swinnen, J.V.; Smans, K. Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids. Prog. Lipid Res., 2013, 52(4), 585-589.
[http://dx.doi.org/10.1016/j.plipres.2013.08.005] [PMID: 24001676]
[113]
Chen, Y.; Li, P. Fatty acid metabolism and cancer development. Sci. Bull. , 2016, 2016, 61.
[114]
Pardo, J.C.; Ruiz de Porras, V.; Gil, J.; Font, A.; Puig-Domingo, M.; Jordà, M. Lipid metabolism and epigenetics crosstalk in prostate cancer. Nutrients, 2022, 14(4), 851.
[http://dx.doi.org/10.3390/nu14040851] [PMID: 35215499]
[115]
Nieman, K.M.; Kenny, H.A.; Penicka, C.V.; Ladanyi, A.; Buell-Gutbrod, R.; Zillhardt, M.R.; Romero, I.L.; Carey, M.S.; Mills, G.B.; Hotamisligil, G.S.; Yamada, S.D.; Peter, M.E.; Gwin, K.; Lengyel, E. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med., 2011, 17(11), 1498-1503.
[http://dx.doi.org/10.1038/nm.2492] [PMID: 22037646]
[116]
Camarda, R.; Zhou, A.Y.; Kohnz, R.A.; Balakrishnan, S.; Mahieu, C.; Anderton, B.; Eyob, H.; Kajimura, S.; Tward, A.; Krings, G.; Nomura, D.K.; Goga, A. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat. Med., 2016, 22(4), 427-432.
[http://dx.doi.org/10.1038/nm.4055] [PMID: 26950360]
[117]
Deng, H.; Li, W. Monoacylglycerol lipase inhibitors: Modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders. Acta Pharm. Sin. B, 2020, 10(4), 582-602.
[http://dx.doi.org/10.1016/j.apsb.2019.10.006] [PMID: 32322464]
[118]
Bononi, G.; Poli, G.; Rizzolio, F.; Tuccinardi, T.; Macchia, M.; Minutolo, F.; Granchi, C. An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present). Expert Opin. Ther. Pat., 2021, 31(2), 153-168.
[http://dx.doi.org/10.1080/13543776.2021.1841166] [PMID: 33085920]
[119]
Prüser, J.L.; Ramer, R.; Wittig, F.; Ivanov, I.; Merkord, J.; Hinz, B. The Monoacylglycerol Lipase Inhibitor JZL184 inhibits lung cancer cell invasion and metastasis via the CB1 cannabinoid receptor. Mol. Cancer Ther., 2021, 20(5), 787-802.
[http://dx.doi.org/10.1158/1535-7163.MCT-20-0589] [PMID: 33632876]
[120]
Ray, K.K.; Bays, H.E.; Catapano, A.L.; Lalwani, N.D.; Bloedon, L.T.; Sterling, L.R.; Robinson, P.L.; Ballantyne, C.M. Safety and efficacy of bempedoic acid to reduce LDL cholesterol. N. Engl. J. Med., 2019, 380(11), 1022-1032.
[http://dx.doi.org/10.1056/NEJMoa1803917] [PMID: 30865796]
[121]
Venant, H.; Rahmaniyan, M.; Jones, E.E.; Lu, P.; Lilly, M.B.; Garrett-Mayer, E.; Drake, R.R.; Kraveka, J.M.; Smith, C.D.; Voelkel-Johnson, C. The sphingosine kinase 2 inhibitor ABC294640 reduces the growth of prostate cancer cells and results in accumulation of dihydroceramides In Vitro and In Vivo. Mol. Cancer Ther., 2015, 14(12), 2744-2752.
[http://dx.doi.org/10.1158/1535-7163.MCT-15-0279] [PMID: 26494858]
[122]
Britten, C.D.; Garrett-Mayer, E.; Chin, S.H.; Shirai, K.; Ogretmen, B.; Bentz, T.A.; Brisendine, A.; Anderton, K.; Cusack, S.L.; Maines, L.W.; Zhuang, Y.; Smith, C.D.; Thomas, M.B. A phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors. Clin. Cancer Res., 2017, 23(16), 4642-4650.
[http://dx.doi.org/10.1158/1078-0432.CCR-16-2363] [PMID: 28420720]
[123]
Pal, S.K.; Drabkin, H.A.; Reeves, J.A.; Hainsworth, J.D.; Hazel, S.E.; Paggiarino, D.A.; Wojciak, J.; Woodnutt, G.; Bhatt, R.S. A phase 2 study of the sphingosine‐1‐phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. Cancer, 2017, 123(4), 576-582.
[http://dx.doi.org/10.1002/cncr.30393] [PMID: 27727447]
[124]
Visweswaran, M.; Arfuso, F.; Warrier, S.; Dharmarajan, A. Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells. Stem Cells, 2020, 38(1), 6-14.
[http://dx.doi.org/10.1002/stem.3101] [PMID: 31648395]
[125]
Pillai, S.; Mahmud, I.; Mahar, R.; Griffith, C.; Langsen, M.; Nguyen, J.; Wojtkowiak, J.W.; Swietach, P.; Gatenby, R.A.; Bui, M.M.; Merritt, M.E.; McDonald, P.; Garrett, T.J.; Gillies, R.J. Lipogenesis mediated by OGR1 regulates metabolic adaptation to acid stress in cancer cells via autophagy. Cell Rep., 2022, 39(6), 110796.
[http://dx.doi.org/10.1016/j.celrep.2022.110796] [PMID: 35545051]
[126]
Snaebjornsson, M.T.; Janaki-Raman, S.; Schulze, A. Greasing the wheels of the cancer machine: The role of lipid metabolism in cancer. Cell Metab., 2020, 31(1), 62-76.
[http://dx.doi.org/10.1016/j.cmet.2019.11.010] [PMID: 31813823]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version290msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[00:03:18] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[00:03:18] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[00:03:18] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[00:03:18] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (102ms)time
  • Application (188ms)time
  • 1 x Application (64.72%)
    188ms
    1 x Booting (35.28%)
    102ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    36 statements were executed, 4 of which were duplicates, 32 unique. Show only duplicated111ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('51368230','',1,1740528198,1740528198) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740528198
      970μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('51368230','/article/131962',1,1740528198,1740528198)
      200μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 51368230 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51368230) limit 1
      11.84msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 51368230
      • 1: 51368230
      • 2: 51368230
      • 3: 51368230
      • 4: 51368230
      • 5: 51368230
      • 6: 51368230
      • 7: 51368230
      • 8: 51368230
      • 9: 51368230
      • 10: 51368230
      • 11: 51368230
      • 12: 51368230
      • 13: 51368230
      • 14: 51368230
      • 15: 51368230
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=131962
      650μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 38 limit 1
      750μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 38
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and sj.journal_id!=38 group by `j`.`nid`) as `aggregate_table`
      1.11msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and sj.journal_id!=38 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      930μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      1.78msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      1.5msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '131962'
      220μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 131962
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '131962'
      5.31msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 131962
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '131962' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      3.01msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 131962
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      270μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      480μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 38 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      31.56msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 38 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      20.88msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 38 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      15.31msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 131962 limit 1
      250μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 131962
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 131962 and content_type = 'article' order by status desc limit 1
      270μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 217145 limit 1
      500μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 217145
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      250μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'CTMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      380μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: CTMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '131962' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      390μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '12605' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      370μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '3330' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      320μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3330) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3330) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3330)
      4.27msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 12605) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 12605) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 12605)
      600μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 131962) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 131962) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51368230 and j.to_ip >=51368230 )) and ((j.from_date <= 1740528198 and j.to_date >= 1740528198 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 131962)
      620μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '1090' and is_uploaded = 1 and issue_id = 12605 order by cast(first_page as SIGNED) desc limit 1
      490μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 1090
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '1103' and is_uploaded = 1 and issue_id = 12605 order by cast(first_page as SIGNED) asc limit 1
      610μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 1103
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      190μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      230μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 131962 limit 1
      2.31msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 131962
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 38 and `b`.`banner_from_date` <= 1740528198 and `b`.`banner_to_date` >= 1740528198 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.14msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 38
      • 3: 1740528198
      • 4: 1740528198
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 38 and `b`.`banner_from_date` <= 1740528198 and `b`.`banner_to_date` >= 1740528198 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.12msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 38
      • 3: 1740528198
      • 4: 1740528198
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='92e2809d9cd24c40735e72d271e29de5'
      340μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        JQhHNvSb3bLhcrk04TKUHSGE3NMo9P0YYKZj8prA
        uc_cart_id
        92e2809d9cd24c40735e72d271e29de5
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/131962" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/131962
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:8 [ "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        []
        
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Wed, 26 Feb 2025 00:03:18 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImNvdExqeEZFc2c5L05DZ2RtT2hQNXc9PSIsInZhbHVlIjoiMDJRZitlQ1k4OEFYVnNiTTRWY3ZwN0RWenIzZTFrQWdnRlQ0MlRXS3hFcWxmZnlGamZhZ0pJL1g3aldmSERialhlSnFVVjlBRGE5bTV0azNMNjJKY2NQZmpGemZoQmp3cTloUmMyQmdXbVBLdERZUWJJZ3NKNUIxeXlhdS9KK2UiLCJtYWMiOiI2NTRhZGM4NDhhZjYyOWQ0ZWMwMzEyNGU0M2E4OTMzNzRkNzE5NzZmNGYzNmUwNWQ1OWQ2YmM2ZDBjZWVjZDI5IiwidGFnIjoiIn0%3D; expires=Fri, 28 Feb 2025 12:03:18 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6ImNvdExqeEZFc2c5L05DZ2RtT2hQNXc9PSIsInZhbHVlIjoiMDJRZitlQ1k4OEFYVnNiTTRWY3ZwN0RWenIzZTFrQWdnRlQ0MlRXS3hFcWxmZnlGamZhZ0pJL1g3aldmSERialhlSnFVV" 1 => "alphaeurekaselectnet_session=eyJpdiI6Ilp2cjFiMGlqemFnczZjd3BhQVd6OGc9PSIsInZhbHVlIjoicjhjRWJjbTN3VGpNdkZRSlc3VjNyYy9pdkt1Kzg3TE5CYmdKT09SNnY3YjF2MEFML2plQ1lDaE8wZUMzYlFBZ05HTXhxYkZqakllaDJ5dk1iWFZVejB0c0drWjl3UmtpY3dTWndMZ2xxZ3RhcXRmVmFtT2RrNUFpWVR6cm81UGQiLCJtYWMiOiIwZjUwNDIxZDBmZmI0N2ZiYjkzMjdkNWQzMjhkZmZmZWY2MWM3NTQyZTEzOTE2MTU0OGZiZjRmM2Y0MDlhM2YyIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6Ilp2cjFiMGlqemFnczZjd3BhQVd6OGc9PSIsInZhbHVlIjoicjhjRWJjbTN3VGpNdkZRSlc3VjNyYy9pdkt1Kzg3TE5CYmdKT09SNnY3YjF2MEFML2plQ1lDaE8" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImNvdExqeEZFc2c5L05DZ2RtT2hQNXc9PSIsInZhbHVlIjoiMDJRZitlQ1k4OEFYVnNiTTRWY3ZwN0RWenIzZTFrQWdnRlQ0MlRXS3hFcWxmZnlGamZhZ0pJL1g3aldmSERialhlSnFVVjlBRGE5bTV0azNMNjJKY2NQZmpGemZoQmp3cTloUmMyQmdXbVBLdERZUWJJZ3NKNUIxeXlhdS9KK2UiLCJtYWMiOiI2NTRhZGM4NDhhZjYyOWQ0ZWMwMzEyNGU0M2E4OTMzNzRkNzE5NzZmNGYzNmUwNWQ1OWQ2YmM2ZDBjZWVjZDI5IiwidGFnIjoiIn0%3D; expires=Fri, 28-Feb-2025 12:03:18 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6ImNvdExqeEZFc2c5L05DZ2RtT2hQNXc9PSIsInZhbHVlIjoiMDJRZitlQ1k4OEFYVnNiTTRWY3ZwN0RWenIzZTFrQWdnRlQ0MlRXS3hFcWxmZnlGamZhZ0pJL1g3aldmSERialhlSnFVV" 1 => "alphaeurekaselectnet_session=eyJpdiI6Ilp2cjFiMGlqemFnczZjd3BhQVd6OGc9PSIsInZhbHVlIjoicjhjRWJjbTN3VGpNdkZRSlc3VjNyYy9pdkt1Kzg3TE5CYmdKT09SNnY3YjF2MEFML2plQ1lDaE8wZUMzYlFBZ05HTXhxYkZqakllaDJ5dk1iWFZVejB0c0drWjl3UmtpY3dTWndMZ2xxZ3RhcXRmVmFtT2RrNUFpWVR6cm81UGQiLCJtYWMiOiIwZjUwNDIxZDBmZmI0N2ZiYjkzMjdkNWQzMjhkZmZmZWY2MWM3NTQyZTEzOTE2MTU0OGZiZjRmM2Y0MDlhM2YyIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6Ilp2cjFiMGlqemFnczZjd3BhQVd6OGc9PSIsInZhbHVlIjoicjhjRWJjbTN3VGpNdkZRSlc3VjNyYy9pdkt1Kzg3TE5CYmdKT09SNnY3YjF2MEFML2plQ1lDaE8" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "JQhHNvSb3bLhcrk04TKUHSGE3NMo9P0YYKZj8prA" "uc_cart_id" => "92e2809d9cd24c40735e72d271e29de5" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/131962" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-26 00:03:18GET/article/131962414361